Trials / Not Yet Recruiting
Not Yet RecruitingNCT07363096
Single- Versus Two-Level ESP Block for Analgesia After Lumbar Stabilization Surgery
Comparison Of Single- Versus Two-Level Erector Spinae Plane Block For Postoperative Analgesia In Patients Undergoing Lumbar Stabilization Surgery
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Ankara Etlik City Hospital · Other Government
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Lumbar stabilization surgery is commonly associated with moderate to severe postoperative pain. Effective pain control is important to improve patient comfort, early mobilization, and recovery. The erector spinae plane (ESP) block is a regional anesthesia technique that has been increasingly used for postoperative pain management in spine surgery. This study aims to compare the effectiveness of single-level versus two-level ultrasound-guided ESP block for postoperative pain control in patients undergoing lumbar stabilization surgery. Patients will be randomly assigned to receive either a single-level ESP block or a two-level ESP block in addition to standard analgesic treatment. Postoperative pain scores, opioid consumption, and the incidence of side effects will be evaluated during the postoperative period. The results of this study may help determine the most effective ESP block technique for pain management after lumbar stabilization surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Single-Level Erector Spinae Plane Block | Ultrasound-guided erector spinae plane block performed at a single vertebral level for postoperative analgesia. |
| PROCEDURE | Two-Level Erector Spinae Plane Block | Ultrasound-guided erector spinae plane block performed at two adjacent vertebral levels for postoperative analgesia. |
Timeline
- Start date
- 2026-02-01
- Primary completion
- 2027-01-01
- Completion
- 2027-01-03
- First posted
- 2026-01-23
- Last updated
- 2026-01-23
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT07363096. Inclusion in this directory is not an endorsement.